Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Reports Third Quarter Financial Results  
10/24/2012 10:07:49 AM

Questcor Pharmaceuticals, Inc. (QCOR) today reported financial results for the third quarter and nine months ended September 30, 2012. Net sales for the third quarter were $140.3 million, reflecting expanded physician usage of H.P. Acthar® Gel (repository corticotropin injection) in the treatment of serious, difficult-to-treat autoimmune and inflammatory disorders. Net sales in the third quarter of 2011 were $59.8 million.